The U.S. government will no longer penalize American companies for making six popular peptides

MarketWatch•Wed, Oct 28, 2026, 08:07 PM•2 min read

It won’t take action against compounding pharmacies that make popular wellness products like BPC-157 and TB-500.

Source: [MarketWatch](https://www.marketwatch.com/story/trump-administration-clears-the-way-for-production-of-peptides-like-bpc-157-and-tb-500-28ac2d11?mod=mw_rss_topstories)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at MarketWatch ↗

More Headlines

FinanceCNBC• 4m ago

Bessent says 'not necessarily' a mistake if the Fed hikes again

Treasury Secretary Scott Bessent joined CNBC for an interview on Oct. 28, 2026.

FinanceCNBC• 5m ago

DoorDash's deal to buy Instacart coming as early as Thursday morning, sources tell CNBC

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 6m ago

Alphabet's free cash flow sinks further, Q3 capex expectations miss in worrying sign for AI trade

Alphabet faces a skeptical Wall Street as it prepares to report quarterly results.

FinanceSeeking Alpha• 9m ago

SK hynix: A Bargain For The Ages (Earnings Analysis)

Developing story — details emerging. Check the source link for the latest updates.

FinanceCryptoSlate• 9m ago

Robinhood posts record $1.4 billion revenue, but a 14% profit drop exposes hidden portfolio losses

Prediction markets generated $173 million against crypto's $120 million in Q3, raising the stakes of a continuing state-federal regulatory fight. Read the full story on CryptoSlate Understand the crypto stories that matter and what to watch next.

FinanceSeeking Alpha• 9m ago

BXP, Inc. (BXP) Q3 2026 Earnings Call Transcript

Developing story — details emerging. Check the source link for the latest updates.